Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jan 8, 2009

Intradigm has named Philip Haworth as its new CEO, replacing Mohammad Azab who has resigned the position (see related story, this issue).
Haworth was previously Intradigm’s vice president of business development. Before that, he held various senior executive roles at biotechnology companies including Genencor and Cor Therapeutics.
Azab remains on Intradigm’s board of directors, the company noted.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.